138730-81-1Relevant articles and documents
DNA alkylation by pyrrole-imidazole seco-CBI conjugates with an indole linker: Sequence-specific DNA alkylation with 10-base-pair recognition through heterodimer formation
Minoshima, Masafumi,Bando, Toshikazu,Sasaki, Shunta,Shinohara, Ken-Ichi,Shimizu, Tatsuhiko,Fujimoto, Jun,Sugiyama, Hiroshi
, p. 5384 - 5390 (2007)
The sequence-specific DNA alkylation by conjugates 4 and 5, which consist of N-methylpyrrole (Py)-N-methylimidazole (Im) polyamides and 1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benz[e]indole (seco-CBI) linked with an indole linker, was investigated in the absence or presence of partner Py-Im polyamide 6. High-resolution denaturing Polyacrylamide gel electrophoresis revealed that conjugate 4 alkylates DNA at the sequences 5′-(A/T)GCCTA- 3′ through hairpin formation, and alkylates 5′-GGAAA-GAAAA-3′ through an extended binding mode. However, in the presence of partner Py-Im polyamide 6, conjugate 4 alkylates DNA at a completely different sequence, 5′-AGGTTGTCCA-3′. Alkylation of 4 in the presence of 6 was effectively inhibited by a competitor 7. Surface plasmon resonance (SPR) results indicated that conjugate 4 does not bind to 5′-AGGTTGTCCA-3′, whereas 6 binds tightly to this sequence. The results suggest that alkylation proceeds through heterodimer formation, indicating that this is a general way to expand the recognition sequence for DNA alkylation by Py-Im seco-CBI conjugates.
CHEMICAL LINKERS WITH SINGLE AMINO ACIDS AND CONJUGATES THEREOF
-
, (2008/12/08)
The present disclosure provides drug-ligand conjugates that are potent cytotoxins and include a linker between the drug and ligand where the linker has a single amino acid. The disclosure is also directed to compositions containing the drug-ligand conjugates, and to methods of treatment using them.
Synthesis and preliminary cytotoxicity study of glucuronide derivatives of CC-1065 analogues
Wang, Yuqiang,Yuan, Huiling,Wright, Susan C.,Wang, Hong,Larrick, James W.
, p. 1569 - 1575 (2007/10/03)
Glucuronide derivatives of CBI-bearing CC-1065 analogues have been synthesized, and their cytotoxicities tested against U937 leukemia cells. The new compounds show potent antitumor activity in vitro. Compounds 1 and 2, and their corresponding glucuronides